Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neuro-Oncology
Published in: Journal of Neuro-Oncology 1/2017

01-10-2017 | Letter to the Editor

Significant response of pituitary carcinoma to carboplatin, leucovorin and fluorouracil chemotherapy: a pediatric case report and review of the literature

Authors: Mohamed S. AbdelBaki, Steven G. Waguespack, Violeta Salceda, Jeremy Jones, Stacie L. Stapleton, David S. Baskin, M. Fatih Okcu

Published in: Journal of Neuro-Oncology | Issue 1/2017

Login to get access

Excerpt

To the Editor, …
Literature
1.
Heaney AP (2011) Pituitary carcinoma: difficult diagnosis and treatment. J Clin Endocrinol Metab 12:3649–3660CrossRef
2.
Lim S, Shahinian H, Maya M et al (2006) Temozolamide: a novel treatment for pituitary carcinoma. Lancet Oncol 7:518–520CrossRefPubMed
3.
Dworakowska D, Wlodek E, Leontiou CA (2009) Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors. Endocr Relat Cancer 16:1329–1338CrossRefPubMed
4.
McCabe CJ, Boelaert K, Tannahill LA (2002) Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 87:4238–4244CrossRefPubMed
5.
Jouanneau E, Wierinckx A, Ducray F (2012) New targeted therapies in pituitary carcinoma resistant to temozolomide. Pituitary 15:37–43CrossRefPubMed
6.
Oritz LD, Syro LV, Scheithauer BW (2011) Anti-VEGF therapy in pituitary carcinoma. Pituitary 15:445–449CrossRef
Metadata
Title
Significant response of pituitary carcinoma to carboplatin, leucovorin and fluorouracil chemotherapy: a pediatric case report and review of the literature
Authors
Mohamed S. AbdelBaki
Steven G. Waguespack
Violeta Salceda
Jeremy Jones
Stacie L. Stapleton
David S. Baskin
M. Fatih Okcu
Publication date
01-10-2017
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 1/2017
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-017-2554-1

Other articles of this Issue 1/2017

Journal of Neuro-Oncology 1/2017 Go to the issue

Clinical Study

Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study

Clinical Study

Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience

Topic Review

Ischemic stroke after radiation therapy for pituitary adenomas: a systematic review

Clinical Study

Expression and prognostic value of JAM-A in gliomas

Clinical Study

A French retrospective study on clinical outcome in 102 choroid plexus tumors in children

Clinical Study

Temporal evolution of perfusion parameters in brain metastases treated with stereotactic radiosurgery: comparison of intravoxel incoherent motion and dynamic contrast enhanced MRI